🇺🇸Stock Analyst🔥 🔥

📈 US Stocks Chief CFA Strategist | Senior Trader | Risk Management Strategist | Follow me for the latest daily updates. Not Financial Advice 🇺🇸

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

🔥US market: endless potential, direction defines winners.

🔥Level up your trading—follow elite-level guidance.

🔥Click: 👉https://t.co/P3ewBrE7gz

🔥Inside our WhatsApp group: sharp trends, no-BS strategies, real-time profit alerts.
#Stocks #Trading #Investing #wealthbuilding

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

I'm conducting live trading in a WhatsApp group!

I will share every trade I make in my WhatsApp group, including the exact entry and exit points.

Stock market enthusiasts are welcome to join!
👇 👇
https://t.co/PtYZoNuLdi

Limited spots available, first come, first served!

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$INTS
2025 milestones; $20M+ funding; Phase 2 amendment; Nasdaq extension.

Strengths: DfuseRx anti-cancer; INT230-6 95% necrosis; cash to '27 Q2.

Rise Today: From 3.18% gain; clinical optimism; funding confidence.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$CGNX
News: Q4 '25 revenue $252M (+10%), EPS $0.27 beat; $500M buyback, dividend.

Strengths: AI vision leader; 99.9% accuracy; $642M cash, no debt.

Rise Today: Earnings surprise drove 25.15% jump; strong '26 outlook.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$GNLN
Company: Cannabis accessories, vaporizers, crypto diversification.

Strengths: Diverse brands, global distribution, innovative health/crypto products.

Recent News: BERA token agreements signed Feb 4/9, 2026.

Rise Today: +28.25% after-hours to $1.18, crypto momentum.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$TDC
$TDC data analytics platform; scalable MPP, AI/ML integration; hybrid cloud, 40+ years expertise.

Q4 revenue $421M (+3%); EPS $0.74 beat; FY26 guidance EPS $2.55-2.65; AI agents launched.

Stock +17.52% to $34.35; earnings beat, optimistic guidance, AI traction.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$MNTN
CTV ad platform; AI tools, self-serve; high margins (75-80%); CEO Mark Douglas, CCO Ryan Reynolds.

Q4 2025 revenue $87M (+36%); EBITDA $28M; 3,632 clients; 2026 guidance $345-355M revenue.

Stock +32.23% to $10.57; Q4 EPS beat ($0.43 vs $0.23); strong growth, cash $210M.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

I'm conducting live trading in a WhatsApp group!

I will share every trade I make in my WhatsApp group, including the exact entry and exit points.

Stock market enthusiasts are welcome to join!
👇 👇
https://t.co/PtYZoNuLdi

Limited spots available, first come, first served!

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$QNCX
Stock Surge: Up 85.15% to $0.2407 pre-market; notable intraday gains.

Strategic Impact: LifeSci Capital explores M&A/sale options; optimism boosts shareholder value.

Market Boost: Oversold RSI spurs buying; volume rise strengthens rally.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$MBOT
2026 milestones: SIR full launch, >$4M revenue; $630K IIA grant for manufacturing.

Strong IP (13 patents), global expansion via CE Mark by 2026 end.

Recent grants, IP gains fuel speculative rebound from $1.62 low.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$FEED
RSU grant; Series H funding; U-Deliver distro; VP appoint; ENFit launch; name change.

Innovative ENvue tech; FDA cleared; non-invasive devices; partnerships; market expansion.

Today's Rise: SEC filing buzz; distro optimism; speculative buys; 23.63% gain.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$ARTL ~$1.47-1.61; Strong Buy, target $11.50-30.60.

Nasdaq compliance extension; $50M financing; CBD praise.

Lipid therapies pipeline; Clinical progress; IP and partnerships.

Rise: Compliance relief, funding optimism.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$TNON
up 19.53% to $0.85-0.88; Strong Buy, target $3.

Q4 rev +90%, full year +20%; New SImmetry+ system; $2.85M financing.

Innovative SI fusion tech; High fusion rates; Market expansion.

Rise: Earnings guidance optimism.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$QNST
AI-driven marketplace; strong growth; resilient position; acquisition potential.

Q2 FY26 earnings beat; HomeBuddy acquisition; AI enhancements.

Today's Rise: Up 22.6%; earnings reaction; acquisition boost; breakout.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$RBLX
Leading UGC game platform, strong user & creator ecosystem.

Q4 2025 Earnings: Revenue $1.42B (+43%), DAU 144M (+69%).

2026 Guidance: Bookings $8.28-8.55B, Revenue $6.02-6.29B.

Stock Rise: +9.44% due to beats & optimistic outlook.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$WHLR
Grocery-anchored REIT in Southeast US; low-competition markets; strong cash flow; debt optimization.

Q3 2025 earnings up; preferred stock redemptions; convertible notes adjusted.

Today's Surge: Up 36.07%; thin float, speculation; no clear catalyst.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$BNAI surged 26.99%.

Driven by termination of $50M equity purchase agreement.

Reduces dilution risk, strengthens balance sheet. Combined with completed private placement.

Signals improved capital discipline and financial control. Sparked strong investor confidence.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$NXL
News: Peer-reviewed DIFS studies; Nasdaq non-compliance; FDA meeting; Q3 revenue drop.

Strengths: Patented neurostimulation; FDA approvals; Strong liquidity; 52% revenue growth.

Rise: Neuroimaging news drove 17.47% pre-market; High volume squeeze.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$CISS
News: Acquired two MR tankers; 1-for-20 reverse split; Imperial holds 81.9%.

Strengths: Debt-free; Fleet up 230%; 17% ROE.

Rise: Ownership filing triggered 38.16% pre-market gain.

[🇺🇸Stock Analyst🔥 🔥 @TrendTrader_777]

$SMCI
Recent News: Q2 rev $12.7B (+123% YoY); FY26 guidance $4B+; NVIDIA Rubin support.

Company Strengths: AI/GPU servers; modular/liquid-cooled designs; $13B backlog; NVIDIA partnerships.

Today's Surge: Earnings beat; AI demand; guidance uptick (10.55% rise).